Highlighting Positive Results in Comparison to Valchlor(R) and in Real-World Use PRINCETON, N.J., March 23, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...
To revive a dead political culture that could lead to a Republican becoming governor in one of the nation’s most Democratic states, the billionaire former investor is talking to voters.
Highlighting Positive Results in Comparison to Valchlor® and in Real-World Use PRINCETON, N.J., March 23, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: ...
Morning Overview on MSN
Xiaomi’s SU7 signals Tesla no longer sets the EV pace by itself
Xiaomi, the Chinese electronics giant best known for smartphones and smart-home gadgets, said it took 50,000 orders for its ...
State health officials have a new plan on addressing one of Michigan's most prevalent genetic disorders. Michigan Department ...
Mount Sinai researchers have published the first organ-wide human skin spatial atlas from across the body. It provides an ...
Completed target enrollment in Phase 1 monotherapy dose expansion study of micvotabart pelidotin (MICVO) in 2L+ ...
OR Royalties Inc. (“OR Royalties ” or the “Company ”) (OR: TSX & NYSE) is pleased to announce the appointment of Mr. Patrick Godin as an Independent Director to its Board of Directors (the “Board ”).
Sol-Gel Technologies Ltd. (the 'Company”) (NASDAQ: SLGL) today announced the pricing of an underwritten offering of 459,112 ordinary shares (the 'Shares”) at a price of $72.00 per Share, resulting in ...
Objective Drug-related problems (DRPs), which encompass medication errors (MEs), adverse drug reactions and adverse drug events (ADEs), represent significant challenges in healthcare settings. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results